Доктор медицинских наук
CEO группы клиник «Saisei Mirai»
Доктор Медицинских Наук
Graduated from Kyoto Prefectural University of Medicine in 1978.
At the age of 33, after gaining experience working in the internal medicine department at a general hospital as a physician, he established Inui Clinic for the treatment of internal diseases.
He soon came to develop a reputation for careful and heartwarming medical examinations which made him popular with patients.
After the loss of his father due to cancer, he came to realize the limitations of conventional therapies for cancer such as surgery, chemothearapy anticancer drugs and radiation therapy, and he started his new practice specializing in immunotherapy for cancer. He also changed his clinic name to Inui Immunotherapy Cancer Clinic.
In 2010 he established Saisei Mirai Kobe Clinic in Kobe Japan.
Currently the clinic is cooperating with medical institutions in Japan as well as overseas, and carrying out research and development of new immunotherapies, such as GcMAF, autologous cancer vaccines, and hyper T/NK cell therapy.
|1978||Graduated from Kyoto Prefectural University of Medicine.|
|1978||University Hospital, Kyoto Prefectural University of Medicine. Worked in the first course for internal medicine.|
|1980||Japanese Red Cross Kyoto Daini Hospital. Worked in the emergency medical care center.|
|1980||Japanese Red Cross Kyoto Daini Hospital. Worked in internal medicine.|
|1987||Opened Inui Cancer Immunotherapy Clinic in Osaka Japan.|
|2009||Incorporated the medical institution Saisei Mirai.|
Inaugurated as the chairman of the board of directors.
|2009||Opened Keihan Saisei Medical Center in Osaka Japan.|
|2010||Opened Saisei Mirai Kobe Clinic, Kobe Japan.|
|2010||Began developing Second Generation High Dose GcMAF in collaboration with Tokushima University in Japan.|
|2011||Began production of 2nd Generation High Dose GcMAF in our Cell Processing Center (CPC) followed by clinical use for patients.|
|2012||Opened Saisei Mirai iTokyo Clinic, Tokyo Japan.|
|2013||Opened Saisei Mirai Keihan Clinic, Osaka Japan.|
|2013||Kyoto Prefectural University of Medicine, serve as a visiting professor.|
|2018||Ritsumeikan University, serve as a visiting professor.|
Medical Doctor, PhD
Dr. Galyna Kutsyna is originally from the eastern Ukraine. She obtained medical degree and completed Internship on neurology in 1995 at Luhansk’s Medical University, Ukraine. For the next eight years she was working as neurologist in small Ukrainian hospital. This was a time to realize that used in neurology therapeutic approaches are mostly symptomatic.
Later on she shifted her specialization in to immunology and infectious diseases. She passed postgraduate training on Infectious Diseases and obtained PhD degree for study immunopathogenesis of Chronic Fatigue Syndrome. In 2004 at University of Montpellier, France, she passed Advanced Course for Physicians in HIV infections. On 2006-2007 there was another postgraduate training in HIV and TB at North Manchester General Hospital, Manchester, UK. Her later scientific interests predominantly devoted the study of interaction human immune system with viral pathogens. From 2008 to 2010 she was invited as a visiting fellow at the Retroviral Vaccines Section of Basic Research Laboratory, National Cancer Institute, NIH, Bethesda, USA, where she studied mucosal immune response to HIV antigens and worked on HIV vaccine development on animal model.
This work highlighted the future searching the ways of down regulation the non-specific and/or self destroying inflammatory immune response. Now the variety of therapeutic approaches on this direction are successfully used in her clinical practice for treatment chronic infection and autoimmune conditions.
She has fifty three listed on PubMed articles. She received twelve research grants including two from Bill & Melinda Gates Foundation.
Since 2018 she was approved by CDC/ US as a panel physician.
Her current specialization included reproductive immunology, chronic autoimmune diseases, chronic inflammation problems; immune oncology.